Exclusive news, analysis, and commentary on Big Pharma, hospitals, and biotech.
Novo Nordisk has announced a new drug in its pipeline performed much better than Wegovy in helping participants to lose weight.
The company’s stock ran higher after the company buoyed investors’ hopes that its technology will boost a lineup of new popular drugs.
The investigation is targeting so-called middlemen that broker deals between hospitals and pharmaceutical companies.
Thanks to SECURE 2.0, eligible companies can receive up to $16,500 in retirement plan tax credits, making it easier and more affordable than ever to offer a 401(k).
Funding for biotech firms focused on psychedelic treatments is sprouting like mushrooms again. In January, the burgeoning sub-sector of mental health treatment scored its second-highest month for fundraising ever recorded, according to Pitchbook and company data compiled by the Financial…
It’s bulking season at Novo Nordisk. On Monday, the Danish pharma firm behind Wegovy and Ozempic announced an $11 billion deal to significantly expand production capacity for its blockbuster weight-loss drugs. The Weighting Game The massive success of both drugs…
If you’re on WeightWatchers, you love to see numbers go down. But if you run WeightWatchers, well… After a solid and hopeful 2023, shares of WW International (the brand’s official name) just experienced their worst month ever, falling nearly 60%…
Hope you have good insurance. A slew of pharmaceutical giants have raised list prices for 775 drugs already this year, according to a 46brooklyn Research analysis conducted for The Wall Street Journal. Big Pharma, Big Prices Medication price hikes at…
It’s the pharmaceutical industry’s version of Pokémon cards — and the big kids on the playground are hogging all the shiny Charizards. According to a Thursday report from Bloomberg, a US government program designed to incentivize drugmakers to develop treatments…